A multicentric open label non-comparative phase-IV observational study to evaluate safety and reactogenicity of BE's reconstituted Pentavalent DTwPrHepB/HIB vaccine in 6-8 week old healthy infants as per routine EPI Immunization Schedule.

Trial Profile

A multicentric open label non-comparative phase-IV observational study to evaluate safety and reactogenicity of BE's reconstituted Pentavalent DTwPrHepB/HIB vaccine in 6-8 week old healthy infants as per routine EPI Immunization Schedule.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Hib-DTP-hepatitis B vaccine (Primary)
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
  • Focus Adverse reactions
  • Sponsors Biological E Limited
  • Most Recent Events

    • 21 Nov 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
    • 01 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
    • 10 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top